AU2001288410A1 - Use of blood and plasma donor samples and data in the drug discovery process - Google Patents

Use of blood and plasma donor samples and data in the drug discovery process

Info

Publication number
AU2001288410A1
AU2001288410A1 AU2001288410A AU8841001A AU2001288410A1 AU 2001288410 A1 AU2001288410 A1 AU 2001288410A1 AU 2001288410 A AU2001288410 A AU 2001288410A AU 8841001 A AU8841001 A AU 8841001A AU 2001288410 A1 AU2001288410 A1 AU 2001288410A1
Authority
AU
Australia
Prior art keywords
blood
data
drug discovery
discovery process
donor samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288410A
Inventor
Patrick G. Morand
Marc J. Ostro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001288410A1 publication Critical patent/AU2001288410A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
AU2001288410A 2000-08-28 2001-08-27 Use of blood and plasma donor samples and data in the drug discovery process Abandoned AU2001288410A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22791000P 2000-08-28 2000-08-28
US60227910 2000-08-28
PCT/US2001/026593 WO2002017770A2 (en) 2000-08-28 2001-08-27 Use of blood and plasma donor samples and data in the drug discovery process

Publications (1)

Publication Number Publication Date
AU2001288410A1 true AU2001288410A1 (en) 2002-03-13

Family

ID=22854943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288410A Abandoned AU2001288410A1 (en) 2000-08-28 2001-08-27 Use of blood and plasma donor samples and data in the drug discovery process

Country Status (3)

Country Link
US (1) US20020046054A1 (en)
AU (1) AU2001288410A1 (en)
WO (1) WO2002017770A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443996A1 (en) * 2001-04-13 2002-10-24 First Genetic Trust Methods and systems for managing informed consent processes
US20020187483A1 (en) * 2001-04-20 2002-12-12 Cerner Corporation Computer system for providing information about the risk of an atypical clinical event based upon genetic information
US20030078808A1 (en) * 2001-04-28 2003-04-24 Baxter International Inc. A system and method for managing inventory of blood component collection soft goods and for preventing the use of quarantined soft goods
US7983848B2 (en) * 2001-10-16 2011-07-19 Cerner Innovation, Inc. Computerized method and system for inferring genetic findings for a patient
US20030158673A1 (en) * 2002-02-16 2003-08-21 Ingene Institut Fur Genetische Medizin Gmbh Method for creating a blood bank with associated data bank
EP1367395A1 (en) 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnosis of neoplasms with the help of anti-gangliosid-antibodies
EP1369693A1 (en) * 2002-06-04 2003-12-10 B.R.A.H.M.S Aktiengesellschaft Method for the diagnosis of sepsis and the control of donor blood with the help of anti-asialo ganglioside antibodies
WO2004046996A1 (en) * 2002-11-18 2004-06-03 Hitachi, Ltd. Information processing system using base sequence-related information
US20040172293A1 (en) * 2003-01-21 2004-09-02 Paul Bruschi Method for identifying and communicating with potential clinical trial participants
EE200500028A (en) * 2003-03-04 2005-10-17 Intresco B.V. Method for linking a biological sample in a depositary and / or information related thereto with data from a sample donor
US20050102161A1 (en) * 2003-03-31 2005-05-12 Kalthoff Robert M. Secure network gateway for accessible patient data and transplant donor data
US7363170B2 (en) * 2004-07-09 2008-04-22 Bio Array Solutions Ltd. Transfusion registry network providing real-time interaction between users and providers of genetically characterized blood products
WO2007108855A2 (en) * 2006-03-17 2007-09-27 Haemonetics Corporation Method and system for patient information processing and management
FI7296U1 (en) * 2006-07-11 2006-11-16 Coronaria Feedback Oy Electronic follow-up system for medicines to be sold to consumers and events
EP2044431B1 (en) * 2006-07-17 2019-04-24 H. Lee Moffitt Cancer Center & Research Institute, Inc. Computer systems and methods for selecting subjects for clinical trials
US8495011B2 (en) * 2007-08-08 2013-07-23 The Patient Recruiting Agency, Llc System and method for management of research subject or patient events for clinical research trials
US20120284037A1 (en) * 2011-05-06 2012-11-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computer program product for receiving a notification of a benefit after queuing the result of an evaluation of a sample for transmission
CA2841808A1 (en) * 2011-07-13 2013-01-17 The Multiple Myeloma Research Foundation, Inc. Methods for data collection and distribution
US9797903B2 (en) 2012-10-24 2017-10-24 Winthrop-University Hospital Non-invasive biomarker to identify subject at risk of preterm delivery
US10366780B2 (en) 2014-01-24 2019-07-30 Elligo Health Research, Inc. Predictive patient to medical treatment matching system and method
CA2953942C (en) * 2014-06-30 2023-10-03 QIAGEN Redwood City, Inc. Methods and systems for interpretation and reporting of sequence-based genetic tests
US10665328B2 (en) * 2014-06-30 2020-05-26 QIAGEN Redwood City, Inc. Methods and systems for interpretation and reporting of sequence-based genetic tests
US10658073B2 (en) 2014-08-15 2020-05-19 QIAGEN Redwood City, Inc. Methods and systems for interpretation and reporting of sequence-based genetic tests using pooled allele statistics
AU2018331400A1 (en) 2017-09-13 2020-04-02 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
JP7019200B2 (en) 2017-11-13 2022-02-15 ザ マルチプル ミエローマ リサーチ ファウンデーション， インコーポレイテッド An integrated molecular, omics, immunotherapy, metabolic, epigenetic, and clinical database
CA3110491A1 (en) * 2018-08-26 2020-03-05 Haemonetics Corporation System and method for remotely obtaining donor information
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
CN115340313B (en) * 2022-01-17 2023-04-18 浙江理工大学 Method for reinforcing recycled aggregate by physical compound microbial technology

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558638A (en) * 1993-04-30 1996-09-24 Healthdyne, Inc. Patient monitor and support system
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5911132A (en) * 1995-04-26 1999-06-08 Lucent Technologies Inc. Method using central epidemiological database
US5664109A (en) * 1995-06-07 1997-09-02 E-Systems, Inc. Method for extracting pre-defined data items from medical service records generated by health care providers
US5809493A (en) * 1995-12-14 1998-09-15 Lucent Technologies Inc. Knowledge processing system employing confidence levels
US5970499A (en) * 1997-04-11 1999-10-19 Smith; Kurt R. Method and apparatus for producing and accessing composite data
US5915240A (en) * 1997-06-12 1999-06-22 Karpf; Ronald S. Computer system and method for accessing medical information over a network
US5991729A (en) * 1997-06-28 1999-11-23 Barry; James T. Methods for generating patient-specific medical reports
US5956689A (en) * 1997-07-31 1999-09-21 Accordant Health Services, Inc. Systems, methods and computer program products for using event specificity to identify patients having a specified disease
US6014631A (en) * 1998-04-02 2000-01-11 Merck-Medco Managed Care, Llc Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry
US6730477B1 (en) * 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
WO2000020634A1 (en) * 1998-10-01 2000-04-13 Nova Molecular, Inc. Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
US6196971B1 (en) * 1999-04-02 2001-03-06 Agilent Technologies, Inc. Chord propagation velocity measurement system and method for an ultrasound imaging system
US7054823B1 (en) * 1999-09-10 2006-05-30 Schering Corporation Clinical trial management system
US20020077849A1 (en) * 2000-01-28 2002-06-20 Baruch Howard M. System and method for improving efficiency of health care
US20030208454A1 (en) * 2000-03-16 2003-11-06 Rienhoff Hugh Y. Method and system for populating a database for further medical characterization
AU2001275095A1 (en) * 2000-07-17 2002-01-30 Opt-E-Scrip, Inc. Single-patient drug trials used with accumulated database
WO2002009004A1 (en) * 2000-07-21 2002-01-31 Surromed, Inc. Computerized clinical questionnaire with dynamically presented questions
CA2420400A1 (en) * 2000-08-24 2002-02-28 Veritas Medicine, Inc. Recruiting a patient into a clinical trial

Also Published As

Publication number Publication date
WO2002017770A2 (en) 2002-03-07
WO2002017770A3 (en) 2002-06-13
US20020046054A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2001288410A1 (en) Use of blood and plasma donor samples and data in the drug discovery process
AU2002211420A1 (en) Methods and devices for processing blood samples
AU2002309528A1 (en) Blood glucose tracking apparatus and methods
AU2001296809A1 (en) Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2002211389A1 (en) Microfluidic devices and methods of use
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU2002341876A1 (en) Methods and devices for treating diseased blood vessels
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001255655A1 (en) Treatment analysis systems and methods
AU6925400A (en) Gabapentin tablet and method of making with improved physical and chemical characteristics
AU2001249389A1 (en) Modified blood clotting factors and methods of use
AU3450400A (en) Liquid centrifuging apparatus and use of same
AU3450500A (en) Centrifuging device and use of same
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2001288061A1 (en) Drug resistance-associated gene and use thereof
AU2001229770A1 (en) Improved research and development process
AU2001285683A1 (en) Mild enrichment of foetal cells from peripheral blood and use thereof
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
AU2001251489A1 (en) Assembly for extracorporeal blood handling and method of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001264488A1 (en) Gene expression cassette and its use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof